Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Market Pulse: Weak Business Investments Driving Slow Economic Growth

By R&D Editors | August 1, 2016

The R&D Index: Market Watch for the week ending July 29, 2016 closed at 1,550.74 for the 25 companies in the R&D Index. The Index was up 1.25 percent (or 19.2 basis points) over the week ending July 22, 2016, or a gain of 9.5 percent over the past five weeks. Seventeen of the 25 R&D Index companies saw gains from Microsoft (0.2 percent) to Astra Zeneca (9.7 percent). Eight stocks had losses for the week from Oracle (-0.1 percent) to Ford Motor (-8.5 percent). For the fourth consecutive week the average for all three R&D Index categories rose in value last week

While the past several weeks have shown strong growth in stock valuations, the overall U.S. economy is declining. According to a report released Friday by the Dept. of Commerce, U.S. GDP grew at a seasonally and inflation-adjusted rate of just 1.2 percent in the second quarter, well below expectations and the weakest start to a year since 2011. This data contrasts with other data, such as 4.9 percent unemployment, increasing wages, post-recession record high home sales, and an increase of 4.2 percent in consumer spending in the second quarter—the highest in two years. On the other side of the economic coin, business investment declined for the third consecutive quarter in the second quarter, inventories declined in the second quarter and government spending continues to decline (in line with budget projections). In general, the decline in business investments includes a decline in R&D investments. Historically, industrial R&D investments have shown strong links to overall GDP growth.

The weak economic data released last week, was reaffirmed when the Federal Reserve stated it would not raise short-term interest rates last Wednesday at its regularly scheduled July meeting. Its release, however, stated that it would still like to have a rate increase this year, possibly as early as September. As opposed to previous stock perturbations, last week’s Fed rate decision had no effect on stock sales.

Oil supplies continued to increase last week, pushing prices down to about $42/barrel, down from about $51/barrel in early June. Inventories are more than 10 percent higher than they were a year ago. And while U.S. and Canadian oil-sand production has declined, foreign production has increased. Most analysts are unconcerned about the current situation and don’t see any major changes in the short-term, either in demand or in supply.

There was a bit of news concerning Apple last week. First, its second-quarter quarterly profit fell 27 percent–the second consecutive quarter—but this beat analysts’ expectations and Apple stock rose 6 percent. There also were some administrative reassignments for Apple’s secret autonomous, electric-vehicle initiative (Project Titan), which has several hundred people are working on.

    Ticker Exchange 2015 R&D billions$ 07/22/16 07/29/16 7/29/16 to 7/22/16 7/29/16 to 1/1/16
1 Microsoft MSFT NASDAQ 12,448 56.57 56.68 0.19% 2.16%
2 Intel INTC NASDAQ 12,128 34.66 34.86 0.58% 1.19%
3 Roche Holdings RHHBY OTC 10,242 31.69 32.09 1.26% -6.90%
4 Toyota TM NYSE 9,112 109.68 111.60 1.75% -9.30%
5 Johnson & Johnson JNJ NYSE 9,046 125.03 125.23 0.16% 21.91%
6 Novartis NVS NYSE 8,935 83.51 83.26 -0.30% -3.28%
7 Apple AAPL NASDAQ 8,397 98.66 104.21 5.63% -1.00%
8 Pfizer PFE NYSE 7,690 36.74 36.89 0.41% 13.89%
9 General Motors GM NYSE 7,500 32.16 31.54 -1.93% -7.26%
10 Merck & Co. MRK NYSE 6,704 58.82 58.66 -0.27% 11.06%
11 Ford Motor F NYSE 6,700 13.84 12.66 -8.53% -10.15%
12 Cisco CSCO NASDAQ 6,411 30.71 30.53 -0.59% 12.41%
13 Oracle ORCL NYSE 6,042 41.08 41.04 -0.10% 12.35%
14 Astra Zeneca PLC AZN NYSE 5,997 31.13 34.14 9.67% 0.56%
15 Honda HMC NYSE 5,990 26.82 27.12 1.12% -15.06%
16 Bristol-Myers Squibb BMY NYSE 5,920 75.68 74.81 -1.15% 8.74%
17 Qualcomm QCOM NASDAQ 5,833 61.15 62.58 2.34% 25.21%
18 Sanofi SA SNY NYSE 5,519 42.31 42.63 0.76% -0.05%
19 Eli Lilly Co LLY NYSE 5,331 81.59 82.89 1.59% -1.60%
20 GlaxoSmithKline GSK NYSE 5,250 43.88 45.07 2.71% 11.70%
21 IBM IBM NYSE 5,247 162.07 160.62 -0.89% 16.75%
22 Daimler DDAIY OTC 5,169 59.51 60.82 2.20% -21.93%
23 Siemens SIE XETRA 4,929 94.82 97.12 2.43% 8.06%
24 Bayer AG BAYN XETRA 4,649 92.07 96.22 4.51% -17.19%
25 Ericsson ERIC NASDAQ 4,124 7.36 7.47 1.49% -22.27%
      Total 175,313 1531.54 1550.74 1.25% 1.92%
                 
      Biopharmaceutical 702.45 711.89 1.34% 2.48%
      Automotive 242.01 243.74 0.71% -13.25%
      ICT   484.90 490.52 1.16% 9.87%

About the R&D Index/Market Pulse

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2014 were selected based on the latest listings from Schonfeld & Associates’ June 2015 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT  (7) and conglomerate (2) organizations who invested a cumulative total of more than $170 billion in R&D in 2014, or approximately 10.8% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2014 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Microsoft, Intel, Roche Holdings, Novartis, Johnson & Johnson, Pfizer, Toyota Motor, General Motors, Merck & Co., Ford Motor, Cisco, Apple Computer, Sanofi SA, Qualcomm, IBM, Astra Zeneca plc, Honda Motor, Daimler, Oracle, GlaxoSmithKline, Siemens, Eli Lilly Co., Ericsson, Bristol-Myers Squibb and Bayer AG. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.3 and $11.7 billion annually on their R&D efforts.

Related Articles Read More >

NSF caps indirect costs at 15% for new university grants
NSF chief quits as DOGE drives 55% budget cut and grant freeze
China could outspend the U.S. on R&D by 30%‑plus by 2030—even if the trade war roars on
White House clampdown puts $1 billion more at risk after $2.3 billion Harvard freeze
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE